309 related articles for article (PubMed ID: 29971600)
1. Gene therapy strategies in the treatment of hypertrophic cardiomyopathy.
Prondzynski M; Mearini G; Carrier L
Pflugers Arch; 2019 May; 471(5):807-815. PubMed ID: 29971600
[TBL] [Abstract][Full Text] [Related]
2. MYBPC3 in hypertrophic cardiomyopathy: from mutation identification to RNA-based correction.
Behrens-Gawlik V; Mearini G; Gedicke-Hornung C; Richard P; Carrier L
Pflugers Arch; 2014 Feb; 466(2):215-23. PubMed ID: 24337823
[TBL] [Abstract][Full Text] [Related]
3. Targeting the population for gene therapy with MYBPC3.
Carrier L
J Mol Cell Cardiol; 2021 Jan; 150():101-108. PubMed ID: 33049255
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of MYBPC3 trans-Splicing and Gene Replacement as Therapeutic Options in Human iPSC-Derived Cardiomyocytes.
Prondzynski M; Krämer E; Laufer SD; Shibamiya A; Pless O; Flenner F; Müller OJ; Münch J; Redwood C; Hansen A; Patten M; Eschenhagen T; Mearini G; Carrier L
Mol Ther Nucleic Acids; 2017 Jun; 7():475-486. PubMed ID: 28624223
[TBL] [Abstract][Full Text] [Related]
5. Homology-directed repair of an MYBPC3 gene mutation in a rat model of hypertrophic cardiomyopathy.
Nie J; Han Y; Jin Z; Hang W; Shu H; Wen Z; Ni L; Wang DW
Gene Ther; 2023 Jun; 30(6):520-527. PubMed ID: 36765144
[TBL] [Abstract][Full Text] [Related]
6. Gene Therapy in Cardiology: Is a Cure for Hypertrophic Cardiomyopathy on the Horizon?
Paratz ED; Mundisugih J; Rowe SJ; Kizana E; Semsarian C
Can J Cardiol; 2024 May; 40(5):777-788. PubMed ID: 38013066
[TBL] [Abstract][Full Text] [Related]
7. The R820W mutation in the MYBPC3 gene, associated with hypertrophic cardiomyopathy in cats, causes hypertrophic cardiomyopathy and left ventricular non-compaction in humans.
Ripoll Vera T; Monserrat Iglesias L; Hermida Prieto M; Ortiz M; Rodriguez Garcia I; Govea Callizo N; Gómez Navarro C; Rosell Andreo J; Gámez Martínez JM; Pons Lladó G; Cremer Luengos D; Torres Marqués J
Int J Cardiol; 2010 Nov; 145(2):405-407. PubMed ID: 20542340
[TBL] [Abstract][Full Text] [Related]
8. Hypertrophic cardiomyopathy clinical phenotype is independent of gene mutation and mutation dosage.
Viswanathan SK; Sanders HK; McNamara JW; Jagadeesan A; Jahangir A; Tajik AJ; Sadayappan S
PLoS One; 2017; 12(11):e0187948. PubMed ID: 29121657
[TBL] [Abstract][Full Text] [Related]
9. Whole-exome sequencing identifies rare compound heterozygous mutations in the MYBPC3 gene associated with severe familial hypertrophic cardiomyopathy.
Zhou N; Qin S; Liu Y; Tang L; Zhao W; Pan C; Qiu Z; Wang X; Shu X
Eur J Med Genet; 2018 Aug; 61(8):434-441. PubMed ID: 29524613
[TBL] [Abstract][Full Text] [Related]
10. Hypertrophic cardiomyopathy: the future of treatment.
Tuohy CV; Kaul S; Song HK; Nazer B; Heitner SB
Eur J Heart Fail; 2020 Feb; 22(2):228-240. PubMed ID: 31919938
[TBL] [Abstract][Full Text] [Related]
11. Diltiazem prevents stress-induced contractile deficits in cardiomyocytes, but does not reverse the cardiomyopathy phenotype in Mybpc3-knock-in mice.
Flenner F; Geertz B; Reischmann-Düsener S; Weinberger F; Eschenhagen T; Carrier L; Friedrich FW
J Physiol; 2017 Jun; 595(12):3987-3999. PubMed ID: 28090637
[TBL] [Abstract][Full Text] [Related]
12. Generation of bi-allelic MYBPC3 truncating mutant and isogenic control from an iPSC line of a patient with hypertrophic cardiomyopathy.
Warnecke N; Ulmer BM; Laufer SD; Shibamiya A; Krämer E; Neuber C; Hanke S; Behrens C; Loos M; Münch J; Kühnisch J; Klaassen S; Eschenhagen T; Patten-Hamel M; Carrier L; Mearini G
Stem Cell Res; 2021 Aug; 55():102489. PubMed ID: 34375846
[TBL] [Abstract][Full Text] [Related]
13. Rescue of cardiomyopathy through U7snRNA-mediated exon skipping in Mybpc3-targeted knock-in mice.
Gedicke-Hornung C; Behrens-Gawlik V; Reischmann S; Geertz B; Stimpel D; Weinberger F; Schlossarek S; Précigout G; Braren I; Eschenhagen T; Mearini G; Lorain S; Voit T; Dreyfus PA; Garcia L; Carrier L
EMBO Mol Med; 2013 Jul; 5(7):1128-45. PubMed ID: 23716398
[TBL] [Abstract][Full Text] [Related]
14. Hypertrophic cardiomyopathy in a Portuguese population: mutations in the myosin-binding protein C gene.
Cardim N; Perrot A; Santos S; Morgado P; Pádua M; Ferreira S; Reis RP; Monteiro C; Ferreira T; Correia JM; Osterziel KJ
Rev Port Cardiol; 2005 Dec; 24(12):1463-76. PubMed ID: 16566405
[TBL] [Abstract][Full Text] [Related]
15. Activation of Autophagy Ameliorates Cardiomyopathy in
Singh SR; Zech ATL; Geertz B; Reischmann-Düsener S; Osinska H; Prondzynski M; Krämer E; Meng Q; Redwood C; van der Velden J; Robbins J; Schlossarek S; Carrier L
Circ Heart Fail; 2017 Oct; 10(10):. PubMed ID: 29021349
[TBL] [Abstract][Full Text] [Related]
16. CRISPR/Cas9 editing in human pluripotent stem cell-cardiomyocytes highlights arrhythmias, hypocontractility, and energy depletion as potential therapeutic targets for hypertrophic cardiomyopathy.
Mosqueira D; Mannhardt I; Bhagwan JR; Lis-Slimak K; Katili P; Scott E; Hassan M; Prondzynski M; Harmer SC; Tinker A; Smith JGW; Carrier L; Williams PM; Gaffney D; Eschenhagen T; Hansen A; Denning C
Eur Heart J; 2018 Nov; 39(43):3879-3892. PubMed ID: 29741611
[TBL] [Abstract][Full Text] [Related]
17. Spectrum of MYBPC3 Gene Mutations in Patients with Hypertrophic Cardiomyopathy, Reporting Two Novel Mutations from North-West of Iran.
Emrahi L; Tabrizi MT; Gharehsouran J; Ardebili SM; Estiar MA
Clin Lab; 2016; 62(5):757-64. PubMed ID: 27348999
[TBL] [Abstract][Full Text] [Related]
18. Nationwide study on hypertrophic cardiomyopathy in Iceland: evidence of a MYBPC3 founder mutation.
Adalsteinsdottir B; Teekakirikul P; Maron BJ; Burke MA; Gudbjartsson DF; Holm H; Stefansson K; DePalma SR; Mazaika E; McDonough B; Danielsen R; Seidman JG; Seidman CE; Gunnarsson GT
Circulation; 2014 Sep; 130(14):1158-67. PubMed ID: 25078086
[TBL] [Abstract][Full Text] [Related]
19. Evolution of genetic testing and gene therapy in hypertrophic cardiomyopathy.
Chiswell K; Zaininger L; Semsarian C
Prog Cardiovasc Dis; 2023; 80():38-45. PubMed ID: 37137376
[TBL] [Abstract][Full Text] [Related]
20. Clinical outcomes associated with sarcomere mutations in hypertrophic cardiomyopathy: a meta-analysis on 7675 individuals.
Sedaghat-Hamedani F; Kayvanpour E; Tugrul OF; Lai A; Amr A; Haas J; Proctor T; Ehlermann P; Jensen K; Katus HA; Meder B
Clin Res Cardiol; 2018 Jan; 107(1):30-41. PubMed ID: 28840316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]